
Emphasizing the proper diagnostic characterization of sidewall aneurysms, the authors of a new study found no significant differences in occlusion status or complications when they compared the approved use of intrasaccular flow disruption for bifurcation aneurysms to off-label treatment of sidewall aneurysms.


















































